Colloidal gold

Introducing the Anbio Lateral Flow Assay (LFA) Solution: Rapid Diagnostic for Laboratory, Point-of-Care, and At-Home Testing

Retrieved on: 
Tuesday, August 15, 2023
LFA, Antigen, Commercial Operating System, Cancer, POC, Continuity test, Viral, Infection, Colloidal gold, Psychological abuse, Biomarker, OTC, Vaccine

FRANKFURT, Germany, Aug. 15, 2023 /PRNewswire/ -- Anbio, a leading provider of innovative diagnostic solutions, proudly presents the Anbio LFA solution, an innovative, easy-to-use, but accurate diagnostic product.

Key Points: 
  • FRANKFURT, Germany, Aug. 15, 2023 /PRNewswire/ -- Anbio, a leading provider of innovative diagnostic solutions, proudly presents the Anbio LFA solution, an innovative, easy-to-use, but accurate diagnostic product.
  • Anbio's LFA solution, or Lateral Flow Assay, is a diagnostic technique for detecting antigens (s) such as viral proteins and cancer biomarkers.
  • Anbio's LFA solution has high specificity, sensitivity, and fast results, perfect for laboratory, over the counter (OTC), and point-of-care (POC) diagnostics.
  • The LFA solution offers several advantages over other point-of-care diagnostic Solutions, including:
    Anbio LFA solution for the qualitative detection of antigens and biomarkers within 20 minutes.

Anbio Biotechnology Highlights the Future of Diagnostic Solutions at AACC 2023

Retrieved on: 
Tuesday, August 1, 2023
Diagnosis, AACC, Colloidal gold, FIA, Lecture, Enzyme, Infection, LAMP, Hormone, POCT, CLIA, Patient, Lateral flow test, IVD, Medical device

FRANKFURT, Germany, Aug. 1, 2023 /PRNewswire/ -- Anbio, a leading provider of innovative diagnostic solutions, made a successful market presence at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo held in Anaheim, CA from July 25-27.

Key Points: 
  • FRANKFURT, Germany, Aug. 1, 2023 /PRNewswire/ -- Anbio, a leading provider of innovative diagnostic solutions, made a successful market presence at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo held in Anaheim, CA from July 25-27.
  • During the tradeshow, Anbio showcased a range of solutions, including CLIA, FIA, LAMP, RT-PCR and Lateral Flow while also demonstrating the operation process of analyzers.
  • The lecture attracted hundreds of attendees, where Michael shared insights into the company's background, comprehensive diagnostic product solutions, and emphasized Anbio's manufacturing capabilities.
  • "AACC 2023 marks the official launch of Anbio's products in the North American market," Michael stated during the lecture.

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

Retrieved on: 
Thursday, April 14, 2022
State Council of the People's Republic of China, HK, COVID-19, Internationalization, Integration, Novel coronavirus, Potyvirus, State Council, NMPA, Research, Capsid, Quarantine, Bacteria, Vehicle registration certificate, Control, RNA, Central nervous system, Medical device, Group, Patient, Fosun Pharma, PROTAC, Coronavirus, Immunomodulation, Metabolism, Human, Innovation, National Medical Products Administration, Certification, Multimedia, Colloidal gold, Joint, Virus, Pharmaceutical industry, Vaccine, Fine chemical, EU

Fosun Diagnostics' Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) adopted the in- vitro qualitative detection method of Novel Coronavirus (2019-nCoV) Nucleocapsid antigen in nasopharyngeal swabsamples from patients with respiratory and fever-related symptoms within 7 days, quarantine observers, and other antigen detection needs.

Key Points: 
  • Fosun Diagnostics' Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) adopted the in- vitro qualitative detection method of Novel Coronavirus (2019-nCoV) Nucleocapsid antigen in nasopharyngeal swabsamples from patients with respiratory and fever-related symptoms within 7 days, quarantine observers, and other antigen detection needs.
  • Fosun Diagnostics' Novel Coronavirus Antigen Detection Kit is equipped with high sensitivity and specificity, strong anti-interference ability and no cross-reactivity among viruses and bacteria.
  • Lately, the State Council's of China under the Joint Prevention & Control for novel coronavirus pneumonia has decided to include antigen detection as a key supplement to nucleic acid detection under the "New Coronavirus Antigen Detection Application Plan (Pilot Trial)".
  • Fosun Diagnostics' Novel Coronavirus Antigen Detection Kit will contribute and continue serving the needs of pandemic prevention and control upon its recent approval.

Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference

Retrieved on: 
Thursday, March 18, 2021
Biotechnology, Life sciences, Branches of biology, Biology, Nucleic acids, Molecular biology, Colloidal gold, Gold, Aptamer, Chemotherapy

ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects.

Key Points: 
  • ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects.
  • The foundational nucleolin-targeting DNA aptamer of ALAN, AS1411, is also a drug candidate for use in treating COVID-19 and other viral-based infectious diseases.
  • STARS is a DNA/RNA-based treatment device candidate for removal from circulating blood of precisely targeted tumor-produced and viral compounds.
  • This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Size matters: Bimodal imaging receives nanoparticle enhancement

Retrieved on: 
Wednesday, March 10, 2021
Nanomedicine, Nanoparticle–biomolecule conjugate, Colloidal gold

Tsukuba, Japan, Mar 10, 2021 - (ACN Newswire) - Scientists have found a way to control the size of special nanoparticles to optimize their use for both magnetic resonance and near-infrared imaging.

Key Points: 
  • Tsukuba, Japan, Mar 10, 2021 - (ACN Newswire) - Scientists have found a way to control the size of special nanoparticles to optimize their use for both magnetic resonance and near-infrared imaging.
  • "Magnetic resonance imaging is routinely used in pre-operative diagnosis, while surgeons have started using near-infrared fluorescence imaging during surgical procedures," says nanobiotechnologist Kyohei Okubo of Tokyo University of Science.
  • Images of blood vessels and organs in live bodies can be obtained with the two imaging techniques by further modifying the nanoparticle surfaces with polyethylene glycol (PEG)-based polymers.
  • But to improve image resolution, scientists need to have more control over nanoparticle size during the fabrication process.

Abingdon Health signs collaboration and co-marketing agreement with Abcam

Retrieved on: 
Tuesday, February 9, 2021
Abcam, Immunologic tests, Abingdon Health, Lateral flow test, Abingdon, Colloidal gold, Companies of the United Kingdom, Medicine, Health care

York, and Cambridge U.K. 09 February 2021: Abingdon Health (AIM:ABDX) (Abingdon or the Company), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a collaboration and co-marketing agreement with Abcam plc (NASDAQ:ABCM; AIM:ABC) (Abcam), a global leader in the supply of life science research tools and reagents.

Key Points: 
  • York, and Cambridge U.K. 09 February 2021: Abingdon Health (AIM:ABDX) (Abingdon or the Company), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a collaboration and co-marketing agreement with Abcam plc (NASDAQ:ABCM; AIM:ABC) (Abcam), a global leader in the supply of life science research tools and reagents.
  • Under the terms of the agreement, Abcam will be the preferred supplier to Abingdon of gold nanoparticles and custom conjugation reagents and services, for the Companys lateral flow assays.
  • We also look forward to working with Abcam to identify and service their customers lateral flow contract development and manufacturing requirements.
  • Mennah Moustafa, Abcams VP of Business Development, commented We are excited to be collaborating with Abingdon Health to provide critical components for their lateral flow tests.

Clene Nanomedicine Receives Patent Notice of Allowance in the United States for using Gold Nanocrystals for the Treatment of Multiple Sclerosis

Retrieved on: 
Tuesday, January 19, 2021
Nanomaterials, Colloidal gold, Gold, Nanoparticle, Nanocrystal

Clene notes that its previously patented gold nanocrystals have surfaces that are substantially free from organic impurities and are therefore clean relative to surfaces of gold nanoparticles made by other processes.

Key Points: 
  • Clene notes that its previously patented gold nanocrystals have surfaces that are substantially free from organic impurities and are therefore clean relative to surfaces of gold nanoparticles made by other processes.
  • This Notice of Allowance comes as we are conducting two Phase 2 studies of our lead drug candidate CNM-Au8 in the treatment of MS, stated Rob Etherington, President and CEO of Clene.
  • MS affects an estimated 1 million people in the U.S. and 2.5 million worldwide, with a treatment market valued at $23 billion globally.
  • New data is expected from Clenes REPAIR-MS Phase 2 study of CNM-Au8 in the second half of 2021.

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification

Retrieved on: 
Monday, December 21, 2020
Medical specialties, Branches of biology, Glycoproteins, Medicine, Immunologic tests, Immunology, ELISA, Antibody, Immunoglobulin G, Colloidal gold, Antibody-dependent enhancement, COVID-19 testing

Based on Beronis SARS-CoV-2 IgG/IgM Antibody Detection Kit, the SARS-CoV-2AntigenTest Kit (Colloidal Gold Method) optimizes the sample collection process.

Key Points: 
  • Based on Beronis SARS-CoV-2 IgG/IgM Antibody Detection Kit, the SARS-CoV-2AntigenTest Kit (Colloidal Gold Method) optimizes the sample collection process.
  • This antigen test kit was prepared using colloidal gold solid-phase immunochromatography.
  • The monoclonal antibody against the core protein of SARS-CoV-2 was labeled on colloidal gold on the glass fiber membrane.
  • At present, Beroni SARS-CoV-2 IgG/IgM Antibody Detection Kit has been exported to Britain, Japan and other countries.

Global Gold Nanoparticles Market Report 2020 Featuring American Elements, Abcam, Cosmo Bio, BBI Solutions, Blacktrace, Creative Diagnostics, Cline Scientific, Cytodiagnostics, Hongwu & 4Basebio

Retrieved on: 
Thursday, December 3, 2020
Chemotherapy, Chemical elements, Chemistry, Physical sciences, Gold nanoparticles in chemotherapy, Colloidal gold, Nanoparticle, Gold

DUBLIN, Dec. 3, 2020 /PRNewswire/ -- The "Gold Nanoparticles - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 3, 2020 /PRNewswire/ -- The "Gold Nanoparticles - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Gold Nanoparticles to Reach $8.8 Billion
    The global market for Gold Nanoparticles is projected to reach US$8.8 billion by the year 2027, trailing a post COVID-19 CAGR of 12.1%, over the analysis period 2020 through 2027.
  • Gold nanoparticles (AuNPs) have a diameter of 1 to 100 nm & can be dispersed in water to form colloidal gold.
  • Reactive oxygen species (ROS) generated by gold nanoparticles helps intensify the oxidative stress of microbial cells, making them effective antimicrobial solutions.

Global Gold Nanoparticles Market Trajectory & Analytics Report 2020: Nano-Coated Materials Emerge as Potent Anti-Virus Weapons of the Future - Market to Reach $8.8 Bn by 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 26, 2020
Health, Biotechnology, Physical sciences, Chemistry, Chemical elements, Electrical conductors, Noble metals, Precious metals, Transition metals, Gold nanoparticles in chemotherapy, Colloidal gold, Nanoparticle, Gold, Silver

The "Gold Nanoparticles - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gold Nanoparticles - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Gold Nanoparticles to Reach $8.8 Billion
    The global market for Gold Nanoparticles is projected to reach US$8.8 billion by the year 2027, trailing a post COVID-19 CAGR of 12.1%, over the analysis period 2020 through 2027.
  • Gold nanoparticles (AuNPs) have a diameter of 1 to 100 nm & can be dispersed in water to form colloidal gold.
  • Reactive oxygen species (ROS) generated by gold nanoparticles helps intensify the oxidative stress of microbial cells, making them effective antimicrobial solutions.